Bluejay Diagnostics Inc (NASDAQ:BJDX) currently has a daily average trading volume of 1.07M but it saw 2530916 shares traded in last market. With a market cap of 1.43M USD, the company’s current market price of $2.58 came rising about 4.03 while comparing to the previous closing price of $2.48. In past 52 weeks, the stock remained buoying in the range of price level as high as $316.92 and as low as $2.22. In the recent trading on the day, stock has struck highest price mark of $2.37 while lowest mark touched by it was $3.6.
Taking a look at 20-day trading activity of Bluejay Diagnostics Inc (BJDX) gives us an average price of $3.86, while its current price level is -99.19% below from 52-week high level whereas it is 16.21% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.81 while that of 200 days or SMA-200 reads an average of $9.98. A closer look into the stock’s movement over the week reveals that its volatility is standing at 42.89% during that period while stretching the period over a month that decreases to 17.55%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 43.10 which implies that the stock is in neutral territory.
Over the week, BJDX’s stock price is moving -20.62% down while it is -35.50% when we observe its performance for the past one month. Year-to-date it is -47.02% down and over the past year, the stock is showing a downside performance of -98.96%.
The company is expected to be releasing its next quarterly report on 2024-Mar-27, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Bluejay Diagnostics Inc’s total number of outstanding shares is 0.55M with 0.69% of that held by the insiders while 6.70% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -358.14% and return on equity (ROE) at -178.98%. Stock’s beta reads 0.41. Stock has a price to book (P/B) ratio of 0.25. Its return on asset (ROA) is -133.92% on average.
